| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT06313593 A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With… |
Enrollment closed, study ongoing |
| 2026-08-13 | NCT06313593 A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With… |
Enrollment reduced: 186 -> 37 participants |
| 2026-08-11 | NCT06843408 A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or… |
Enrollment closed, study ongoing |
| 2026-08-11 | NCT06843408 A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or… |
date change Primary completion pushed: 2026-07-03 -> 2027-01-06 |
| 2026-08-11 | NCT06843408 A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or… |
date change Completion pushed: 2027-12-31 -> 2028-07-20 |
| 2026-08-11 | NCT05936359 A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With… |
Enrollment closed, study ongoing |
| 2026-08-11 | NCT05936359 A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With… |
Enrollment reduced: 225 -> 160 participants |
| 2026-08-07 | NCT07214779 Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants… |
Trial sites expanded: 178 -> 181 locations |
| 2026-08-07 | NCT07623200 A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… |
Recruitment opened |
| 2026-08-07 | NCT07623200 A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… |
Trial sites expanded: 0 -> 180 locations |
| 2026-08-07 | NCT07522073 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS… |
Trial sites expanded: 215 -> 219 locations |
| 2026-07-29 | NCT06959225 Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With… |
Enrollment closed, study ongoing |
| 2026-07-24 | NCT07214779 Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants… |
Trial sites expanded: 169 -> 178 locations |
| 2026-07-24 | NCT06548360 A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric… |
Trial sites reduced: 101 -> 98 locations |
| 2026-07-24 | NCT05836324 A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic… |
Enrollment increased: 408 -> 570 participants |
| 2026-07-24 | NCT05836324 A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic… |
Trial arms changed: 10 -> 12 |
| 2026-07-24 | NCT05836324 A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic… |
Trial sites expanded: 36 -> 39 locations |
| 2026-07-24 | NCT05836324 A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic… |
date change Primary completion pushed: 2027-01-13 -> 2029-05-03 |
| 2026-07-24 | NCT05836324 A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic… |
date change Completion pushed: 2027-01-13 -> 2029-05-03 |
| 2026-07-23 | NCT06804811 A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12… |
Trial sites reduced: 86 -> 79 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06615050 | A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant… | Graft-versus-host Disease (GVHD) | Recruiting |
| NCT06804811 | A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12… | NonSegmental Vitiligo | Recruiting |
| NCT06548360 | A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric… | NonSegmental Vitiligo | Recruiting |
| NCT06585774 | A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic… | Chronic Graft-versus-host-disease | Recruiting |
| NCT06855498 | Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Hidradenitis Suppurativa (HS) | Recruiting |
| NCT07214779 | Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants… | Ovarian Cancer | Recruiting |
| NCT07284849 | A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and… | CRC (Colorectal Cancer) | Recruiting |
| NCT07522073 | A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS… | Solid Tumors | Recruiting |
| NCT07623200 | A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… | Essential Thrombocythemia | Recruiting |
| NCT04680052 | A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and… | Follicular Lymphoma | Active, Not Recruiting |
| NCT06263478 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy… | Chronic Graft-versus-host-disease | Active, Not Recruiting |
| NCT06113445 | A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental… | NonSegmental Vitiligo | Active, Not Recruiting |
| NCT06212999 | A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants… | Hidradenitis Suppurativa (HS) | Active, Not Recruiting |
| NCT06821542 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic… | Chronic Graft-versus-host-disease | Active, Not Recruiting |
| NCT06113471 | A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental… | NonSegmental Vitiligo | Active, Not Recruiting |
| NCT04824092 | Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate… | Diffuse Large B-cell Lymphoma | Active, Not Recruiting |
| NCT06516965 | A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… | Prurigo Nodularis | Active, Not Recruiting |
| NCT05429268 | Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in… | Large B-Cell Lymphoma | Active, Not Recruiting |
| NCT06516952 | A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With… | Prurigo Nodularis | Active, Not Recruiting |
| NCT06832618 | A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and… | Atopic Dermatitis | Active, Not Recruiting |
| NCT06958211 | Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With… | Hidradenitis Suppurativa | Active, Not Recruiting |
| NCT06959225 | Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With… | Hidradenitis Suppurativa | Active, Not Recruiting |
| Phase 2 | |||
| NCT06465433 | Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies… | Hematologic Malignancies | Recruiting |
| NCT05090891 | To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With… | Fibrodysplasia Ossificans Progressiva (FOP) | Recruiting |
| NCT07124078 | A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants… | Chronic Graft-versus-host-disease | Recruiting |